Products (3)
Rivastigmine Transdermal System
47781-304
ANDA204403
ANDA (C73584)
TRANSDERMAL
June 11, 2012
POLYISOBUTYLENE (400000 MW)Inactive
Code: X9N69O5R5XClass: IACT
POLYISOBUTYLENE (1100000 MW)Inactive
Code: FLT10CH37XClass: IACT
RivastigmineActive
Code: PKI06M3IW0Class: ACTIBQuantity: 4.6 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LIGHT MINERAL OILInactive
Code: N6K5787QVPClass: IACT
Rivastigmine Transdermal System
47781-305
ANDA204403
ANDA (C73584)
TRANSDERMAL
June 11, 2012
RivastigmineActive
Code: PKI06M3IW0Class: ACTIBQuantity: 9.5 mg in 1 1
POLYISOBUTYLENE (400000 MW)Inactive
Code: X9N69O5R5XClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LIGHT MINERAL OILInactive
Code: N6K5787QVPClass: IACT
POLYISOBUTYLENE (1100000 MW)Inactive
Code: FLT10CH37XClass: IACT
Rivastigmine Transdermal System
47781-405
ANDA204403
ANDA (C73584)
TRANSDERMAL
June 11, 2012
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POLYISOBUTYLENE (400000 MW)Inactive
Code: X9N69O5R5XClass: IACT
RivastigmineActive
Code: PKI06M3IW0Class: ACTIBQuantity: 13.3 mg in 1 1
LIGHT MINERAL OILInactive
Code: N6K5787QVPClass: IACT
POLYISOBUTYLENE (1100000 MW)Inactive
Code: FLT10CH37XClass: IACT